CURRENT SERIES:
Understanding Axial Spondyloarthritis
December 27, 2018
December 27, 2018
January 03, 2019
January 03, 2019
January 10, 2019
January 10, 2019
January 17, 2019
January 17, 2019
January 24, 2019
February 21, 2019
February 21, 2019
February 28, 2019
February 28, 2019
March 07, 2019
March 07, 2019
March 14, 2019
March 14, 2019
March 21, 2019
March 21, 2019
NOW PLAYING
The Epidemiology of Axial Spondyloarthritis
20 of 22
March 21, 2019
March 28, 2019

The Epidemiology of Axial Spondyloarthritis

Hillary Norton, MD, discusses the epidemiology of axial spondyloarthritis.

Hillary Norton, MD: The epidemiology of axSpA [axial spondyloarthritis] and AS [ankylosing spondylitis] is challenging because these are both underdiagnosed diseases, which makes the epidemiology imperfect. But we do think that the epidemiology for axSpA is 1.7% of the population. And for AS, 0.55% of the population. AxSpA is equivalent between men and women, whereas AS is more common in men.

Symptoms start in the 1920s, which is 1 of the reasons for delay in diagnosis, because generally people who develop back pain in their 20s aren’t aware that this could be a chronic autoinflammatory disease.

This is an invisible disease, and we do know that it’s vastly underdiagnosed. Part of the problem is that when someone develops back pain in their 1920s, they may not go in at all to seek care. When they do, they may go to a chiropractor, a sports medicine physician, or a primary care physician and may not get seen by rheumatology for quite some time. So this leads to the delay in diagnosis.
 
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up